The excitement about cell and gene therapies is almost tangible within the biotech and pharma industry. Over 950 companies are actively developing advanced therapies, which are expected to make exceptional improvements to peoples’ lives in the next decade. ...
The excitement about cell and gene therapies is almost tangible within the biotech and pharma industry. Over 950 companies are actively developing advanced therapies, which are expected to ...
At just two-and-a-half years old, the University of Wisconsin–Madison Human Stem Cell Gene Editing Service is already contemplating expansion, partly because of demand for a new gene ...
Cell therapy product development is notoriously complex, expensive and time-consuming. How can the field reduce complexity during clinical translation of products without sacrificing ...
Building on an R&D tie-up with and Indian stem cell institution last year, UK biotech PhoreMost has begun a collaboration with Japan’s Otsuka working on several gene therapy projects.
Here are 10 European biotech startups that leave a mark on the biotech scene: Oblique Therapeutics – This Swedish biotech company is developing antibody therapeutics using its proprietary ...
bit bio (formerly Elpis Biomed) today announced its founding team, a group of pioneering scientists and business executives at the forefront of stem cell biology, cellular reprogramming and ...
The Raskind lab in the UW Division of Medical Genetics is seeking postdoctoral researchers with an interest in the functional genetics of neurodege...
Having launched near the beginning of the last decade, Toronto-based CCRM has had a ringside seat to the noteworthy advances in our industry —...